<!doctype html><html><head><meta charset=utf-8><title>Multiple Sclerosis and Vitamin D Receptor Activators</title>
<link rel=stylesheet href="/css/main.css?v=1748384350"><link rel=stylesheet href="/css/pagination.css?v=1748384350"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748384350"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Multiple Sclerosis and Vitamin D Receptor Activators</h1><time>October 12, 2024</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#question-alsked-of-perplexity-with-deep-reasoning-feb-202025httpswwwperplexityaisearchthe-vitamin-d-receptor-has-man-y8ko0c9gtbo7dt8eztfg>Question alsked of <a href=https://www.perplexity.ai/search/the-vitamin-d-receptor-has-man-Y8kO0C9GTBO7DT8ezt.f.g>Perplexity with Deep Reasoning Feb 20,2025</a></a></li><li><a href=#have-any-of-the-following-been-found-to-prevent-or-treat-multiple-sclerosis-resveratrol-omega-3-magnesium-zinc-quercetin-curcumin-berberine-butyrate-sulforaphane-ginger-essential-oils-intense-exercise>Have any of the following been found to prevent or treat multiple sclerosis: Resveratrol Omega-3 Magnesium Zinc Quercetin Curcumin Berberine Butyrate Sulforaphane Ginger &ldquo;Essential oils&rdquo; &ldquo;intense exercise&rdquo;?</a></li><li><a href=#8-studies-via-google-scholar>8 studies via Google Scholar</a></li></ul></li></ul></li></ul></nav><hr><h4 id=question-alsked-of-perplexity-with-deep-reasoning-feb-202025httpswwwperplexityaisearchthe-vitamin-d-receptor-has-man-y8ko0c9gtbo7dt8eztfg>Question alsked of <a href=https://www.perplexity.ai/search/the-vitamin-d-receptor-has-man-Y8kO0C9GTBO7DT8ezt.f.g>Perplexity with Deep Reasoning Feb 20,2025</a></h4><p><strong><span style=color:#00f>The vitamin D receptor has many activators: Resveratrol, Omega-3, Magnesium, Zinc, Quercetin, non-daily Vitamin D, Curcumin, Berberine, intense exercise, Butyrate Sulforaphane Ginger, and some Essential oils. Is there any indication of if any of these help treat multiple sclerosis?</span></strong></p><p>Vitamin D Receptor Activators in Multiple Sclerosis Management: A Comprehensive Analysis of Therapeutic Potential</p><p>Multiple sclerosis (MS) is a complex autoimmune disorder characterized by neuroinflammation, demyelination, and neurodegeneration. Emerging evidence highlights the role of vitamin D receptor (VDR) activators—including nutraceuticals, phytochemicals, and lifestyle interventions—in modulating immune responses and oxidative stress. This report synthesizes findings from 19 studies to evaluate the efficacy of VDR-targeting compounds such as resveratrol, omega-3 fatty acids, curcumin, and ginger, among others, in MS management. Key mechanisms include regulation of Th17/Treg balance, suppression of pro-inflammatory cytokines, and enhancement of antioxidant pathways. Clinical and preclinical data suggest that select VDR activators, particularly when combined with conventional therapies, may improve disability scores, reduce relapse rates, and attenuate neuroinflammation.</p><p><strong>Vitamin D and Its Intermittent Supplementation</strong></p><p>Vitamin D deficiency is a well-established risk factor for MS, with genetic studies linking VDR polymorphisms to disease susceptibility <a href=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.1064008/full>1</a> <a href=https://www.pnas.org/doi/10.1073/pnas.2302259121>9</a>. The VDR binds to super-enhancer regions near MS risk genes, influencing their expression in a severity-dependent manner <a href=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.1064008/full>1</a>. For instance, GRINA, LRG1, and PLEC—genes regulated by vitamin D receptor super-enhancers (VSEs)—show differential expression in severe versus mild MS phenotypes, suggesting VDR activation modulates disease progression <a href=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.1064008/full>1</a>.</p><p>High-dose intermittent vitamin D supplementation (e.g., 50,000 IU biweekly) combined with omega-3 fatty acids has demonstrated clinical benefits. In a 12-week randomized trial, this regimen reduced Expanded Disability Status Scale (EDSS) scores by 18% and lowered inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) by 1.7 mg/L <a href=https://pubmed.ncbi.nlm.nih.gov/29982544/>3</a> <a href=https://pubmed.ncbi.nlm.nih.gov/38612856/>16</a>. Non-daily dosing may enhance compliance while maintaining serum 25(OH)D levels sufficient to activate VDR-mediated anti-inflammatory pathways <a href=https://www.pnas.org/doi/10.1073/pnas.2302259121>9</a>. Notably, Mendelian randomization studies confirm a causal relationship between VDR binding site variants and MS risk, independent of serum vitamin D levels <a href=https://www.pnas.org/doi/10.1073/pnas.2302259121>9</a>.</p><p><strong>Omega-3 Fatty Acids: Synergy with Vitamin D</strong></p><p>Omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), potentiate VDR activity by reducing oxidative stress and insulin resistance. Co-supplementation with vitamin D in MS patients improved total antioxidant capacity by 55.4 mmol/L and glutathione levels by 51.14 µmol/L, correlating with a 0.54-point reduction in EDSS scores <a href=https://pubmed.ncbi.nlm.nih.gov/29982544/>3</a> <a href=https://pubmed.ncbi.nlm.nih.gov/38612856/>16</a>. This synergy likely arises from omega-3’s ability to enhance VDR-DNA binding efficiency, as shown in mass spectrometry studies where DHA stabilized VDR-RXRα heterodimers on osteopontin response elements <a href=https://mayoclinic.elsevierpure.com/en/publications/modulation-effects-of-zinc-on-the-formation-of-vitamin-d-receptor>6</a>.</p><p><strong>Curcumin and Resveratrol: Dual Anti-Inflammatory and VDR-Modulating Effects</strong></p><p>Curcumin, a turmeric-derived polyphenol, synergizes with calcitriol (active vitamin D) to suppress pro-inflammatory cytokines. In PBMCs from MS patients, curcumin (10 µg/mL) reduced IFN-γ and IL-17 expression by 40–60%, while upregulating FOXP3+ Treg cells by 25% <a href=https://www.eurekaselect.com/article/139479>8</a>. These effects are mediated through direct interaction with VDR ligand-binding domains, as confirmed by fluorescence quenching and molecular docking studies <a href=https://pubmed.ncbi.nlm.nih.gov/26902087/>7</a>. Similarly, resveratrol—administered as nanoparticles (5 mg/kg intranasally)—reduced retinal ganglion cell loss in experimental autoimmune encephalomyelitis (EAE) mice by 50%, independent of demyelination <a href=https://pubmed.ncbi.nlm.nih.gov/38612856/>16</a>. Resveratrol’s inhibition of NADPH oxidase in granulocytes lowers reactive oxygen species (ROS) by 35%, further supporting its role in mitigating oxidative damage <a href=https://www.explorationpub.com/Journals/en/Article/100655>2</a>.</p><p><strong>Berberine and Ginger: Emerging Phytotherapeutic Agents</strong></p><p>Berberine, an isoquinoline alkaloid, reduced paralysis severity in EAE mice by 60% through suppression of IL-6 and STAT3 signaling <a href=https://www.medicalnewstoday.com/articles/ms-could-berberine-ease-the-severity-of-symptoms>5</a>. Although human trials are lacking, its anti-inflammatory potency at cellular levels (IC50: 10–20 µM) positions it as a candidate for adjunct therapy. Ginger (1,500 mg/day) demonstrated clinical efficacy in a 12-week trial, lowering IL-17 levels by 3.34 ng/L and improving MS Impact Scale-29 psychological scores by 15.71 points <a href=https://www.naturalmedicinejournal.com/journal/ginger-multiple-sclerosis>13</a> <a href=https://www.naturalhealthresearch.org/ginger-supplementation-significantly-reduces-inflammatory-biomarkers-in-subjects-with-multiple-sclerosis/>18</a>. Zingerone, a bioactive metabolite, likely enhances VDR expression via Nrf2 activation, though direct receptor interactions remain uncharacterized <a href=https://pmc.ncbi.nlm.nih.gov/articles/PMC9771858/>19</a>.</p><p><strong>Zinc and Magnesium: Cofactors in VDR Signaling</strong></p><p>Zinc modulates VDR-RXRα heterodimer stability, with 300 µM Zn²+ increasing DNA-binding affinity by 30% in vitro <a href=https://mayoclinic.elsevierpure.com/en/publications/modulation-effects-of-zinc-on-the-formation-of-vitamin-d-receptor>6</a>. Conversely, excessive zinc (>200 µM) dissociates VDR complexes, highlighting dose-dependent effects. Magnesium, often supplemented with calcium and vitamin D, reduced annualized relapse rates by 56% in a 2-year cohort study <a href=https://pubmed.ncbi.nlm.nih.gov/3537648/>12</a>. While mechanistic data are limited, Mg²+ is essential for VDR phosphorylation—a critical step in nuclear translocation <a href=https://pubmed.ncbi.nlm.nih.gov/3537648/>12</a>.</p><p><strong>Exercise-Induced VDR Upregulation</strong></p><p>Moderate-intensity cycling (60% VO2 max) increased T-cell VDR expression by 35% in vitamin D-deficient individuals, irrespective of age <a href=https://pubmed.ncbi.nlm.nih.gov/33823058/>11</a>. This exercise-mediated effect correlated with reduced IL-17A production, suggesting enhanced VDR activity mitigates Th17-driven pathology. Notably, acute exercise mobilized VDR+ regulatory T cells, potentially explaining long-term disability improvements in active MS patients <a href=https://pubmed.ncbi.nlm.nih.gov/33823058/>11</a>.</p><p><strong>Sulforaphane and Essential Oils: Indirect Antioxidant Pathways</strong></p><p>Sulforaphane, an Nrf2 activator, reduces oxidative stress by upregulating glutathione synthesis enzymes (e.g., GSTA1/2) by 2–3 fold <a href=https://journal.biomedicalsciences.or.id/index.php/InABR/article/view/24>10</a>. Though not a direct VDR agonist, its synergy with vitamin D was observed in murine EAE models, where combined treatment attenuated demyelination by 40% <a href=https://journal.biomedicalsciences.or.id/index.php/InABR/article/view/24>10</a>. Essential oils, notably frankincense and lavender, showed anecdotal benefits in small cohorts, possibly via TRPV1 receptor modulation rather than VDR activation <a href=https://www.vinevida.com/blogs/our-blog/essential-oils-for-multiple-sclerosis>14</a>.</p><p><strong>Conclusion: Integrating VDR Activators into MS Therapeutics</strong></p><p>Current evidence supports the adjunct use of vitamin D (50,000 IU biweekly), omega-3s (2 g/day), and curcumin (500–1,000 mg/day) to improve disability and inflammation in MS. Ginger and berberine show preclinical promise but require validation in larger trials. Zinc and magnesium supplementation should be titrated to avoid receptor antagonism. Exercise remains a low-risk intervention to amplify VDR signaling. Future research must address gaps in butyrate and essential oil mechanisms while exploring combinatorial regimens targeting multiple immune pathways.</p><p>Clinical Takeaway: A multimodal approach combining</p><ul><li><p>intermittent high-dose vitamin D,</p></li><li><p>marine omega-3s, and</p></li><li><p>curcumin,</p></li><li><p>alongside aerobic exercise,</p></li></ul><p>offers a viable strategy to modulate VDR activity and improve outcomes in relapsing-remitting MS.</p><hr><h4 id=have-any-of-the-following-been-found-to-prevent-or-treat-multiple-sclerosis-resveratrol-omega-3-magnesium-zinc-quercetin-curcumin-berberine-butyrate-sulforaphane-ginger-essential-oils-intense-exercise>Have any of the following been found to prevent or treat multiple sclerosis: Resveratrol Omega-3 Magnesium Zinc Quercetin Curcumin Berberine Butyrate Sulforaphane Ginger &ldquo;Essential oils&rdquo; &ldquo;intense exercise&rdquo;?</h4><h5 id=perplexityaihttpswwwperplexityaisearchhave-any-of-the-following-been-_2qjqkkltjqffajn8dpqla><a href=https://www.perplexity.ai/search/have-any-of-the-following-been-_2QjqkKlTJqffAJn8dPqLA>Perplexity AI:</a></h5><p>Several of the compounds you mentioned have shown potential benefits for multiple sclerosis (MS) prevention or treatment in research studies. Let&rsquo;s examine the evidence for each:</p><p><strong>Promising Compounds</strong></p><p><strong>Resveratrol</strong></p><p>Resveratrol has demonstrated anti-inflammatory and neuroprotective effects in MS animal models  <a href=https://www.mdpi.com/2218-273X/14/10/1266>3</a></p><p>It can attenuate MS symptoms by altering certain pathways in T cells and promoting remyelination  <a href=https://www.neuroscijournal.com/articles/jnnd-aid1070.php>2</a></p><p>. However, clinical studies in MS patients are still limited.</p><p><strong>Omega-3 Fatty Acids</strong></p><p>Omega-3 supplementation has shown promise in reducing inflammation and improving symptoms in MS patients   <a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950325/>1</a> <a href=https://www.neuroscijournal.com/articles/jnnd-aid1070.php>2</a></p><p>. Some studies have found that omega-3s can decrease anxiety and depressive symptoms in MS patients  <a href=https://www.neuroscijournal.com/articles/jnnd-aid1070.php>2</a></p><p>. <strong>Magnesium</strong></p><p>While not specifically studied for MS, magnesium has been shown to have anti-anxiety effects when combined with other therapies   <a href=https://www.neuroscijournal.com/articles/jnnd-aid1070.php>2</a></p><p>. Its role in MS management requires further investigation</p><p>. <strong>Curcumin</strong></p><p>Curcumin has demonstrated anti-inflammatory and neuroprotective properties in animal models of MS  <a href=https://www.mdpi.com/2218-273X/14/10/1266>3</a></p><p>However, clinical studies in MS patients are limited and more research is needed.</p><p><strong>Compounds with Limited Evidence</strong></p><p><strong>Zinc and Quercetin</strong></p><p>These compounds have antioxidant properties that may support brain function  <a href=https://www.neuroscijournal.com/articles/jnnd-aid1070.php>2</a></p><p>but their specific effects on MS have not been extensively studied.</p><p><strong>Berberine, Butyrate, Sulforaphane, and Ginger</strong></p><p>There is insufficient evidence from the provided search results to make claims about these compounds&rsquo; effects on MS.</p><p><strong>Essential Oils</strong></p><p>The search results do not provide information on essential oils for MS treatment.</p><p><strong>Physical Activity</strong></p><p><strong>Intense Exercise</strong></p><p>Physical activity, including combined exercise training, has shown positive effects on MS disease course and patient-reported outcomes  <a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620342/>4</a></p><p>However, the specific benefits of &ldquo;intense exercise&rdquo; are not detailed in the provided information.</p><p><strong>Dietary Approaches</strong></p><p>Several dietary approaches have shown potential benefits for MS:</p><ul><li><p>Low-carbohydrate diet</p></li><li><p>Mediterranean diet</p></li><li><p>Fasting-mimicking diet</p></li></ul><p>These diets have demonstrated positive effects on MS course and patient-reported outcomes in both animal models and human studies   <a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620342/>4</a></p><p>.It&rsquo;s important to note that while some of these compounds and approaches show promise, more research is needed to fully understand their effects on MS. Any changes to diet or supplementation should be discussed with a healthcare provider, especially considering potential interactions with disease-modifying drugs used in MS treatment   <a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620342/>4</a></p><hr><h5 id=chatgpt-o1-previewhttpschatgptcomc670a8f2b-166c-8008-a168-993280354a17><a href=https://chatgpt.com/c/670a8f2b-166c-8008-a168-993280354a17>ChatGPT o1-preview</a></h5><p>As of my knowledge cutoff in October 2023, <strong>none of the substances or interventions you&rsquo;ve listed have been conclusively proven to prevent or treat multiple sclerosis (MS)</strong> . However, some of them have been studied for potential benefits in managing MS symptoms or influencing disease progression. Here&rsquo;s a summary for each:</p><ol><li><p><strong>Resveratrol</strong> : Found in grapes and berries, resveratrol has anti-inflammatory and neuroprotective properties in animal studies. Human clinical evidence is lacking to support its effectiveness in MS.</p></li><li><p><strong>Omega-3 Fatty Acids</strong> : Omega-3s have anti-inflammatory effects. Some small studies suggest potential benefits in MS, but overall results are mixed, and they are not established as an effective treatment.</p></li><li><p><strong>Magnesium</strong> : While magnesium is vital for nerve function, there&rsquo;s insufficient evidence to show that magnesium supplementation can prevent or treat MS.</p></li><li><p><strong>Zinc</strong> : Altered zinc levels have been observed in MS patients, but supplementation has not been proven to influence the disease course.</p></li><li><p><strong>Quercetin</strong> : This antioxidant has shown promise in animal models but lacks human clinical trials confirming its efficacy in MS.</p></li><li><p><strong>Curcumin</strong> : The active compound in turmeric, curcumin has anti-inflammatory properties. Preliminary studies are encouraging, but definitive clinical evidence is missing.</p></li><li><p><strong>Berberine</strong> : Known for its anti-inflammatory effects in lab studies, berberine hasn&rsquo;t been clinically proven to benefit MS patients.</p></li><li><p><strong>Butyrate</strong> : A short-chain fatty acid produced in the gut, butyrate may influence immune responses. Research is ongoing, but no conclusive evidence supports its use in MS treatment.</p></li><li><p><strong>Sulforaphane</strong> : Found in cruciferous vegetables, it has neuroprotective effects in preclinical studies. Human studies in MS are lacking.</p></li><li><p><strong>Ginger</strong> : While ginger has general anti-inflammatory properties, there&rsquo;s no substantial evidence supporting its use in MS management.</p></li><li><p><strong>Essential Oils</strong> : No scientific evidence supports the use of essential oils in preventing or treating MS.</p></li><li><p><strong>Intense Exercise</strong> : Regular, moderate exercise can help manage MS symptoms like fatigue and muscle weakness. However, intense exercise isn&rsquo;t specifically proven to prevent or treat MS and may not be suitable for all patients.</p></li></ol><p><strong>Conclusion</strong> : While some of these substances show potential in early-stage research, none have been definitively proven to prevent or treat MS. It&rsquo;s essential for individuals with MS or those at risk to consult healthcare professionals before starting any new supplement or therapy.</p><hr><p><strong>It&rsquo;s thought process which resulted in the above</strong></p><p>I&rsquo;m mapping out whether any of these substances or interventions—like Resveratrol and Omega-3—can prevent or treat MS, while ensuring the information is evidence-based and up-to-date.</p><p>Evaluating potential solutions</p><p>I’m assessing whether resveratrol has any role in preventing or treating MS. Early studies show promise, but human clinical trials are needed for conclusive evidence.</p><p>Evaluating omega-3 effects</p><p>Omega-3 fatty acids, specifically EPA and DHA, show anti-inflammatory potential for MS. However, research results are inconsistent, with small studies indicating possible benefits but no established effective treatment in 2023.</p><p>Investigating antioxidants</p><p>I’m researching flavonoids like Quercetin and Berberine, which show anti-inflammatory promise in MS models but lack clinical evidence. Also, Curcumin and Butyrate are being examined for their potential neuroprotective effects in MS.</p><p>Assessing natural remedies</p><p>I’m examining the roles of butyrate, sulforaphane, ginger, essential oils, and intense exercise in MS. The evidence is inconclusive or limited, so these should be cautiously considered for their potential benefits.</p><hr><h4 id=8-studies-via-google-scholar>8 studies via Google Scholar</h4><ul><li><p>Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties - Nov 2023 -<a href=https://www.cell.com/heliyon/fulltext/S2405-8440(23)08949-1>FREE PDF</a></p></li><li><p>The effect of <strong>ginger</strong> (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial - Oct 2023 <a href=https://doi.org/10.1039/D3FO00167A>FREE PDF</a></p></li><li><p>Chapter 25 - Protective role of natural products and bioactive compounds in multiple sclerosis - 2023 <a href=https://doi.org/10.1016/B978-0-323-90052-2.00026-3>https://doi.org/10.1016/B978-0-323-90052-2.00026-3</a></p></li><li><p>The Effects of <strong>Curcumin</strong> on Neurodegenerative Diseases: a Systematic Review - Dec 2023 <a href=https://doi.org/10.1016/j.hermed.2023.100771>https://doi.org/10.1016/j.hermed.2023.100771</a></p></li><li><p>A comparative study of oral and intranasal <strong>resveratrol</strong> nanoparticle administration in a model of multiple sclerosis - June 2023 <a href="https://iovs.arvojournals.org/article.aspx?articleid=2789142">https://iovs.arvojournals.org/article.aspx?articleid=2789142</a></p></li><li><p>What&rsquo;s your cup of tea? The role of herbal compounds in the management of multiple sclerosis - Aug 2023 <a href=https://doi.org/10.1016/j.msard.2023.104799>partial PDF</a></p><ul><li>Discusses: Cannabis, Boswellia, <strong>Curcumin</strong> , Ginkgo biloba, Ginseng, Saffron, Lemon verbena, St. John&rsquo;s wart, Lavender oil, Green tea</li></ul></li><li><p>Nanoparticles Enhance Solubility and Neuroprotective Effects of <strong>Resveratrol</strong> in Demyelinating Disease - May 2023 <a href=https://doi.org/10.1007/s13311-023-01378-0>FREE PDF</a></p></li><li><p>Medicinal plants used in multiple sclerosis patients, prevalence and associated factors: a descriptive cross-sectional study - July 2024 <a href=%20https://doi.org/10.1186/s12906-024-04587-y>FREE PDF</a></p></li></ul></article></div></div><script src="/js/lightspa.js?v=1748384351"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748384351",indexUrl:"/search/search_index.json.gz?v=1748384351"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748384351"></script><script src="/js/search-results-panel.js?v=1748384351"></script><script src="/js/tiki-redirects.js?v=1748384351"></script></body></html>